SEC Form 4 · accession 0001385508-18-000047
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas T. Thomas
Director
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2018 | S | 500 | $16.41 | D | 2,263 | D | |
| Common Stock | May 16, 2018 | S | 263 | $16.17 | D | 2,000 | D | |
| Common Stock | May 17, 2018 | S | 500 | $16.40 | D | 1,500 | D | |
| Common Stock | May 17, 2018 | S | 500 | $16.51 | D | 1,000 | D | |
| Common Stock | May 17, 2018 | S | 500 | $16.50 | D | 500 | D | |
| Common Stock | May 18, 2018 | S | 500 | $16.50 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.